SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001362310-09-007700
Filing Date
2009-05-18
Accepted
2009-05-15 21:55:14
Documents
9
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q c85515e10vq.htm 10-Q 186336
2 EXHIBIT 10.1 c85515exv10w1.htm EX-10.1 310630
3 EXHIBIT 10.2 c85515exv10w2.htm EX-10.2 103396
4 EXHIBIT 10.3 c85515exv10w3.htm EX-10.3 9023
5 EXHIBIT 10.4 c85515exv10w4.htm EX-10.4 34880
6 EXHIBIT 31.1 c85515exv31w1.htm EX-31.1 9314
7 EXHIBIT 31.2 c85515exv31w2.htm EX-31.2 9290
8 EXHIBIT 32.1 c85515exv32w1.htm EX-32.1 4887
9 GRAPHIC c85515c8551501.gif GRAPHIC 11036
  Complete submission text file 0001362310-09-007700.txt   684519
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 09835225
SIC: 2836 Biological Products, (No Diagnostic Substances)